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Purpose: Glycine has a protective effect in renal and skeletal muscle ischemia. The purpose of this study was to evaluate the
effect of glycine in mesenteric ischemia and reperfusion injury in a rat model.
Methods: Twenty-four anesthetized male Sprague-Dawley rats were subjected to 1 hour of mesenteric ischemia followed
by 2 hours of reperfusion. Control animals received normal saline solution intravenously at 0.01 mL/g of body weight/h
during ischemia and reperfusion. Treated animals received glycine at 0.5, 0.75, or 1.0 mg/g of body weight, dissolved in
saline solution and infused at 0.01 mL/g/h for 2 hours. Animals were killed at the end of the experiment, and proximal,
middle, and distal segments of the small bowel were isolated. Sections of the segments stained with hematoxylin-eosin
were subjected to histologic examination (as per modified Chiu grading system) and morphometric analysis consisting of
measurement of bowel wall, muscularis and mucosal thickness, epithelial coverage, and villar circumference. Isometric
tension responses to electrical stimulation (10, 30, 50, 100 Hz), high doses of potassium (120 mmol/L), and carbachol
(0.1, 0.5, 1.0, 5.0 mol/L) were recorded in a multimuscle chamber. Statistical analysis was performed with unpaired t
test and one-way analysis of variance.
Results: The middle and distal segments of the small bowel in glycine-treated animals showed better histologic grade
compared with saline solution–treated control rats (P < .05). At morphometric analysis, total thickness, mucosal
thickness, and villar circumference ratio were well preserved in the middle and distal segments of the small bowel in the
glycine-treated group (P < .05). No significant differences were observed in the proximal bowel segments between
glycine-treated and control animals, because the proximal segment was not subjected to much ischemia. No differences
were noted in percentage of epithelial coverage. Isometric tension responses evoked by electrical stimulation were greater
(P < .05) in the middle and distal segments treated with glycine as compared with control segments. Carbachol-evoked
contractions were stronger (P < .05) in the small bowel segments of animals treated with glycine. The responses evoked
by 120 mmol/L of potassium were stronger in the distal segments of the small bowel in the glycine-treated group (P <
.05). This cytoprotective effect of glycine was not dose-dependent.
Conclusions: Glycine improved mucosal viability in the ischemia and reperfusion injury rat model. Mucosal thickness and
villous circumference ratio were reliable objective parameters for evaluation of intestinal ischemia injury. Glycine
improved the contractile responses of the bowel segments also, probably by altering the physiologic mechanisms
underlying force generation. Further studies are required to elucidate the mechanism of the cytoprotective action of
glycine. (J Vasc Surg 2003;38:1113-20.)
Mesenteric ischemia remains a challenging clinical
problem. The diagnosis is difficult and often delayed. When
bowel infarction occurs, the mortality rate is 70% to 90%.1
However, if ischemic injury to the bowel is suspected,
administration of a cytoprotective agent could be invalu-
able. Various pharmacologic agents have been evaluated to
limit ischemia and reperfusion injury. Administration of
glucagon,2,3 21-amino steroids,4 pentoxyphylline,5 and so-
matostatin,6 and intraluminal perfusion of perfluorocar-
bons7-9 were reported to minimize the ischemic and reper-
fusion injury of the intestine. The neutral amino acid
glycine has a protective effect in isolated ischemic proximal
tubules of rabbit10 and in a canine kidney model.11 The
cytoprotective effect of glycine was also demonstrated in
cultured hepatocytes subjected to hypoxia,12 and in a rat
liver perfusion model.13 We previously demonstrated that
glycine preserves normal function and reduces the necrosis
of skeletal muscle subjected to ischemia and reperfusion
injury.14 Ischemic spinal cord injury is partly attributed to
excessive release of excitatory neurotransmitters,15 and gly-
cine is an inhibitory neurotransmitter between the spinal
interneurons and motor neurons.16 Thus it is possible that
glycine can reduce ischemia and reperfusion injury by virtue
of its neuroprotective effect. The primary purpose of the
present study was to determine whether glycine can reduce
histologic and physiologic damage in the rat small bowel
subjected to mesenteric ischemia and reperfusion injury.
METHODS
Male Sprague-Dawley rats (weighing 450-550 g) ob-
tained from Taconic Farms were used in the experiments.
Each animal was anesthetized with 50 mg/kg of sodium
pentobarbital (Nembutal) injected intraperitoneally. The
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internal jugular vein was cannulated for venous access. The
abdomen was opened, and the bowel was eviscerated. The
superior mesenteric artery was dissected under the operat-
ing microscope, and occluded with a microvascular clamp
for 1 hour. The bowel was returned to the peritoneal cavity,
and the laparotomy wound was closed. During this period
of ischemia, normal saline solution (0.9% NaCl) was in-
fused through the jugular venous catheter at 0.01 mL/g
body weight/h. At the end of the ischemic period, the
abdomen was opened and superior mesenteric circulation
was established by removing the clamp. Then the control
animals received normal saline solution at 0.01 mL/g of
body weight/h for 2 hours. The experimental animals
received glycine at 0.5, 0.75, or 1.0 mg/g of body weight,
dissolved in saline solution and infused at 0.01 mL/g/h for
2 hours. The half-life of glycine is 3.75 mg/g of body
weight in mice,17 and in our preliminary tests infusion of
glycine at 2 mg/g of body weight in the rat resulted in a few
deaths. Thus glycine doses of 1 mg/g or less were used in
the present study. Rats not subjected to ischemia and
reperfusion served as normal control.
At the end of reperfusion, the abdominal incision was
reopened and 3-cm segments were obtained from the
proximal (10 cm from the gastroduodenal junction), distal
(10 cm from the ileocecal junction), and midportions of the
small bowel. Divided portions of these bowel segments
were subjected to histologic examination, morphometric
analysis, and contractility studies.
Histologic analysis. Histologic analysis was per-
formed with bowel segments from 3 control rats and 6
saline solution–treated rats, and 18 rats divided into three
equal groups, each receiving glycine at 0.5, 0.75, or 1.0
mg/g of body weight/h. Paraffin-embedded sections 10
m thick were obtained from each bowel segment and
stained with hematoxylin-eosin. Histologic evaluation was
performed with light microscopy by two blinded observers
on two separate occasions, with the grading system de-
scribed by Chiu et al18 and modified by Oldham et al8
(Table I).
Morphometric analysis. Hematoxylin-eosin–stained
transverse sections were photographed under 40 magni-
fication at light microscopy. Twenty-five to 38 points were
marked at 1-cm intervals on the photograph along the
circumference of the bowel. Total thickness (Fig 1, A),
mucosal thickness (Fig 1, B), and muscularis thickness (Fig
1, C) were measured with a SigmaScan digitizing tablet and
image analysis software (SPSS, Chicago, Ill).
Four quadrants of each transverse section were photo-
graphed under 100 magnification. From each quadrant,
total villar circumference of the bowel segment (Fig 1, D)
and total length at the villar crypt junctions (Fig 1, E) were
measured, and villous circumference ratio was calculated as
D/E. Total villar circumference of the complete quadrant
(T  F to I; Fig 1) and the circumference of the villar
regions not covered by epithelium (N  H1 to H2; Fig 1)
were measured, and percentage of epithelial coverage was
calculated as ([T  N]/T)  100. The values from each
quadrant were added, then divided by 4 to get mean
percent epithelial coverage and villous circumference ratio
for each section.
Monitoring of contractile responses of bowel seg-
ments. Contractility tests were performed with bowel seg-
ments from 3 control, 9 saline-treated, and 9 glycine (0.5
mg/g/h)–treated rats. Tension responses of the proximal,
middle, and distal segments of the small bowel were mon-
itored simultaneously with an in vitro multimuscle cham-
ber19 (Buxeco Electronics Corp, Sharon, Conn). The
chamber consisted of removable glass jar with a thermo-
regulated water jacket and a Lucite muscle holder. Each
small bowel segment was attached to one fixed steel tube at
the bottom of the muscle holder and a 10-cm-long (0.2-
mm-diameter) stainless steel hook at the top. The stainless
steel hook was attached to a FORT 10 force transducer
(WPI Instruments, Sarasota, Fla), which was mounted on a
separate micromanipulator. The bowel segments were elec-
trically stimulated with a pair of platinum plate electrodes
fixed vertically 3 cm apart on the muscle holder. The glass
chamber contained 20 mL of the physiologic solution,
which was continuously oxygenated and maintained at
37°C. The physiologic solution contained 135 mmol/L of
Table I. Histologic grading system
Grade Histologic appearance
0 Normal
1 Subepithelial edema, partial separation of apical cells
2 Epithelial cell slough from tips of villi
3 Progression of slough to base of villi
4 Partial mucosal necrosis of lamina propria
5 Total mucosal necrosis
Fig 1. Morphometric analysis of ileal ischemia-reperfusion injury
with SigmaScan (100). A, Total thickness of bowel wall; B,
mucosal thickness; C, thickness of muscularis; D, total villar cir-
cumference; E, length at base of villi. Villous circumference ratio
calculated as D/E. Total villar circumference covered by epithelium
(T  F to I) and circumference of villar regions not covered by
epithelium (N  H1 to H2) were measured for entire quadrant,
and percentage of epithelial coverage was calculated as ([T 
N]/T)  100.
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NaCl, 5 mmol/L of KC1, 2 mmol/L of CaC12, 1 mmol/L
of MgC12, 1 mmol/L of Na2 HPO4, 15 mmol/L of
NaHCO3, and 11 mmol/L of dextrose, and was continu-
ously bubbled with 95% O2 and 5% CO2. In a typical
experiment, the intestinal segments were allowed to equil-
ibrate in the chamber for 30 minutes. Each segment was
stretched to bear a resting tension of 1.0g, and isometric
contractile responses of the three segments were simulta-
neously monitored.
Electrically evoked contractile responses were obtained
by applying a single square wave pulse or 1-second trains of
square wave pulses of 15 V and 1-ms duration at 10, 30,
and 50 Hz frequency. The stimulus pulses were generated
with a Grass S88 stimulator (Astro-Med, West Warwick,
RI) and amplified with a Hewlett-Packard 6824A power
amplifier (Hewlett-Packard, Palo Alto, Calif). Tension re-
sponses were monitored with a four-channel digital oscil-
loscope (Nicolet Instruments, Madison, Wis) with 2-ms
sampling interval, 60-kilobase (kb) record length, and
2-minute recording time.
Contractile response to potassium is caused by depo-
larization of the muscle membrane, leading to influx of
extracellular activator Ca2 into the myoplasm.20 This
response was evoked by exposing the bowel segments to
prewarmed oxygenated physiologic solution containing
120 mmol/L of potassium. The potassium replaced
equimolar concentration of sodium in the solution. The
contractions were monitored for 2 minutes, with a sam-
pling interval of 2 ms and record length of 60 kb.
Contractile response to carbachol is caused by activa-
tion of muscarinic receptors, leading to release of activator
Ca2 into the myoplasm.21 These responses were evoked
by exposing the bowel segments to the physiologic solution
containing cumulative doses of 0.1, 0.5, 1.0, and 5.0
mol/L of carbachol applied at 1-minute intervals. The
responses were recorded for 5 minutes, with 5-ms sampling
interval and 60 kb record length.
The digitized waveforms of the contractile responses
were stored on 44 megabyte Bernoulli cartridges of the
digital oscilloscope. Amplitude of the responses was mea-
sured offline with waveform analysis software (DADiSP
Corp, Cambridge, Mass).
Animal care. All animals received humane care and
treatment, in compliance with the guidelines for the care
and use of laboratory animals published by the National
Institutes of Health (NIH Publication No. 85-23, revised
1996). They were acclimated before experiments for at
least 72 hours, with food and water available at will. At the
end of the experiment, the animals were killed with admin-
istration of 100 mg/kg of sodium pentobarbital followed
by 80 mEq of potassium. They were observed for 30
minutes before disposal.
Statistical analysis. Statistical analysis was performed
with SigmaStat software (SPSS). All values are expressed as
mean  SE. All tests for significance of difference were
performed for one histologic or contractile parameter in
one regional segment of the small bowel at a time. Differ-
ence in the value of each parameter between normal and
saline solution–treated segments was evaluated with un-
paired t tests. Difference in values of each parameter be-
tween segments treated with saline solution and various
doses of glycine was evaluated with one-way analysis of
variance. The Dunnet test was used for post hoc multiple
comparisons between saline solution–treated control seg-
ments and each glycine-treated segment.
RESULTS
Histologic grade
Histologic grade of sections of proximal, middle, and
distal bowel segments of normal rats ranged from 0.19 to
0.25, without significant differences (Table II). The prox-
imal segment did not show significant changes in histologic
grade after ischemia and reperfusion with saline solution or
treatment with glycine at 0.5, 0.75, and 1.0 mg/g/h
(Table II). The middle segment showed normal histologic
grade in the nonischemic bowel (Fig 2), significantly higher
histologic grade after ischemia and reperfusion with saline
solution (Fig 3), and significantly lower histologic grade
after treatment with glycine at 0.5, 0.75, and 1.0 mg/g/h
(Fig 4; Table 2). The distal segment showed changes
similar to those in the middle segment in histologic grade
(Table II); however, the effect of glycine on histologic
grade of either the middle or distal segments was not
dose-dependent.
Morphometric analysis
Morphometric parameters measured are shown in Fig
1. Mean muscle thickness of the proximal bowel segment of
normal rat was 0.125 m, and was not significantly differ-
ent in the middle and distal segments of normal rat (Table
III). After ischemia and reperfusion with saline solution
there was no significant change in muscle thickness in any
of the bowel segments (Table III). Similarly, there was no
significant change in muscle thickness in any of the bowel
segments after treatment with glycine at 0.5, 0.75, and 1.0
mg/g/h (Table III).
Mean mucosal thickness was 0.82 m in the proximal
bowel segment, 0.77m in the middle segment, and 0.573
Table II. Effect of glycine on histologic grades of
proximal, middle, and distal bowel segments subjected to
mesenteric ischemia and reperfusion
Proximal Middle Distal
Normal 0.20  0.05 0.25  0.08 0.19  0.06
Saline solution 1.30  0.44 3.20  0.90* 2.95  0.57*
Glycine (mg/g/h)
0.5 1.40  0.41 1.55  0.87* 1.32  0.71*
0.75 1.20  0.27 1.30  0.44* 1.50  0.70*
1.0 1.40  0.54 1.80  0.30* 1.40  0.54*
Values represent mean  SE, obtained from three normal rats, six rats
treated with saline solution, and six rats in each group treated with glycine.
For each regional segment of bowel, difference between normal and saline
solution–infused tissues was evaluated with unpaired t test, and difference
between tissues treated with saline solution and glycine was evaluated with
one-way analysis of variance.
*P  .05.
JOURNAL OF VASCULAR SURGERY
Volume 38, Number 5 Kallakuri et al 1115
m in the distal bowel segment of normal rat (Table III).
Mucosal thickness decreased significantly (P  .05) from
proximal to distal axis. After ischemia and reperfusion with
saline solution or at treatment with various doses of glycine,
no significant change was noted in mucosal thickness of the
proximal segment (Table III). In both middle and distal
segments, mucosal thickness decreased significantly (P 
.05) after ischemia and reperfusion with saline solution
(Table III), and increased significantly (P  .05) after
treatment with various doses of glycine, compared with
saline solution–treated segments (Table III). However,
values were still slightly lower than those in normal control
rats (Table III). Total thickness of bowel segments showed
similar changes as for mucosal thickness after ischemia,
reperfusion, and glycine treatment (Table III).
Epithelial coverage was about 98% in all bowel seg-
ments of normal rat (Table IV). It decreased slightly in all
bowel segments after ischemia and reperfusion with saline
solution, and did not show further change with treatment
with glycine at any dose (Table IV).
Mean villar circumference ratio was 11.12 in proximal
bowel segments, 7.15 in middle bowel segments, and 5.82
in distal bowel segments of normal rat (Table IV). Villar
circumference ratio significantly decreased (P  .05) from
proximal to distal axis. In the proximal segment, villar
circumference ratio decreased significantly after ischemia
and reperfusion with saline solution (Table IV). Although
it showed considerable increase after treatment with various
doses of glycine, the change compared with saline solution–
Fig 2. Normal nonischemic ileum (100).
Fig 3. Ileum after 1 hour of ischemia and 2 hours of reperfusion in
saline solution–treated control rats (100).
Fig 4. Ileum after 1 hour of ischemia and 2 hours of reperfusion in
glycine-treated rats (100).
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treated segments was not significant (Table IV). A similar
trend was observed in villar circumference ratio of the
middle segment, although here treatment with glycine at
0.75 to 1.0 mg/g/h showed significant improvement in
the ratio compared with treatment with saline solution
(Table IV). In the distal segment, villar circumference ratio
did not show significant change after saline solution or
glycine treatment (Table IV).
Contractile responses
Proximal segment. Peak value of the contractile re-
sponses evoked with electrical stimulation generally in-
Table IV. Effect of glycine on villar morphometric parameters in proximal, middle, and distal bowel segments subjected
to mesenteric ischemia and reperfusion
Proximal Middle Distal
Percent epithelial coverage
Normal 98.30  1.20 97.60  2.30 98.50  1.90
Saline solution 79.55  9.40 73.50  8.93 95.71  9.45
Glycine (mg/g/h)
0.5 75.91  6.69 74.62  8.23 78.38  11.14
0.75 79.13  7.28 75.99  15.61 72.14  12.62
1.0 85.01  12.23 77.68  9.92 77.77  11.91
Villous circumference ratio
Normal 11.12  1.10 7.15  0.91 5.82  0.71
Saline solution 3.67  0.87* 3.48  0.52† 5.15  0.53
Glycine (mg/g/h)
0.5 7.27  1.84 5.56  0.89 5.57  0.64
0.75 6.87  2.10 5.81  0.24‡ 6.11  0.43
1.0 7.15  1.90 4.93  0.32§ 5.13  0.21
Values represent mean  SE, obtained from three normal rats, six rats treated with saline solution, and six rats in each group treated with glycine. For each
regional segment of bowel, difference between normal and saline solution–infused tissues was evaluated with unpaired t test, and difference between tissues





Table III. Effect of glycine on morphometric parameters of proximal, middle, and distal bowel segments subjected to
mesenteric ischemia and reperfusion
Proximal Middle Distal
Muscle thickness (mm)
Normal 0.125  0.004 0.118  0.004 0.146  0.005
Saline solution 0.210  0.067 0.170  0.000 0.180  0.010
Glycine (mg/g/h)
0.5 0.150  0.000 0.170  0.000 0.170  0.030
0.75 0.200  0.002 0.180  0.000 0.220  0.040
1.0 0.160  0.001 0.190  0.090 0.160  0.020
Mucosal thickness (mm)
Normal 0.820  0.010 0.770  0.011 0.573  0.005
Saline solution 0.760  0.090 0.330  0.080* 0.330  0.030*
Glycine (mg/g/h)
0.5 0.700  0.060 0.620  0.050* 0.560  0.050*
0.75 0.910  0.290 0.710  0.100* 0.480  0.070*
1.0 0.770  0.060 0.600  0.140* 0.530  0.130*
Total thickness (mm)
Normal 0.944  0.009 0.887  0.009 0.719  0.004
Saline solution 1.000  0.160 0.540  0.090* 0.590  0.040*
Glycine (mg/g/h)
0.5 0.860  0.060 0.810  0.080* 0.720  0.005*
0.75 1.150  0.280 0.910  0.130* 0.720  0.004*
1.0 0.960  0.060 0.820  0.090* 0.750  0.011*
Values represent mean  SE, obtained from three normal rats, six rats treated with saline solution, and six rats in each group treated with glycine. For each
regional segment of bowel, difference between normal and saline solution–infused tissues was evaluated with unpaired t test, and difference between tissues
treated with saline solution and glycine was evaluated with one-way analysis of variance.
*P  .05.
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creased with increase in frequency of stimulation from 10
to 30 Hz, and decreased slightly at 50 Hz, in all bowel
segments. At 30 Hz, mean peak contractile tension was
35.7 mg per milligram of tissue in control rats, and did
not differ significantly in saline solution–treated or gly-
cine-treated proximal segments (Fig 5).
Mean value of peak contractile response evoked by 120
mmol/L of potassium was 41.7 mg per milligram of tissue
in control rats, and did not differ significantly in the saline
solution–treated or glycine-treated proximal segments (Fig
5).
Peak value of contractile responses evoked with carba-
chol generally increased with increase in concentration
from 0.1 to 5 mol/L in all bowel segments. At 5 mol/L
of carbachol, mean peak contractile tension was 48.8 mg
per mg of tissue in control proximal segments, and did not
differ significantly in saline solution–treated segments (Fig
5). The carbachol-induced contraction was significantly
higher (P .05) in the glycine- treated segments compared
with saline solution–treated segments (Fig 5).
Middle segment. At 30 Hz, mean maximal contrac-
tile tension was 47.0 mg per milligram of tissue in control
middle segment (Fig 6). Electrically evoked contraction
was slightly lower in the saline solution–treated segment,
but was significantly higher (P .05) in the glycine-treated
segment (Fig 6).
Mean value of peak contractile response evoked with
120 mmol/L of potassium was 45.2 mg per milligram of
tissue in control middle segment and was slightly lower in
saline solution–treated and glycine-treated middle seg-
ments (Fig 6).
At 5 mol/L of carbachol, maximal contractile tension
was 45.2 mg per milligram of tissue in the control middle
segment and was slightly higher in the saline solution–
treated segment (Fig 6). Carbachol-induced contraction
was significantly higher (P  .05) in the glycine-treated
segment compared with the saline solution–treated seg-
ment (Fig 6).
Distal segment. At 30 Hz, mean maximal contractile
tension was 40.2 mg per milligram of tissue in control distal
segments and was slightly lower in saline solution–treated
segments (Fig 7). Electrically-evoked contraction was sig-
nificantly higher (P  .05) in the glycine-treated segment
compared with the saline solution–treated segment (Fig 7).
Mean value of peak contractile response evoked with
120 mmol/L of potassium was 50.5 mg per milligram of
Fig 5. Peak contractile tension responses evoked with electrical
stimulation at 30 Hz, 120 mmol/L of potassium, and 5 mol/L
of carbachol in proximal segment of small bowel in normal, saline
solution–treated, and glycine (0.5 mg/g/h)–treated rats. Bars
represent mean value; vertical lines represent standard error, ob-
tained from number of rats given in parentheses. *Significance of
difference between value of each parameter in saline solution–
treated and glycine-treated segments, evaluated with the Student t
test.
Fig 6. Peak contractile tension responses in middle segment of
small bowel in normal, saline solution–treated, and glycine (0.5
mg/g/h)–treated rats. Bars represent mean value; vertical lines
represent standard error, obtained from number of rats given in
parentheses. *Significance of difference between value of each
parameter in saline solution–treated and glycine-treated segments,
evaluated with the Student t test.
Fig 7. Peak contractile tension responses in middle segment of
small bowel in normal, saline solution–treated, and glycine (0.5
mg/g/h)–treated small bowel of the rats. Bars represent mean
value; vertical lines represent standard error, obtained from num-
ber of rats given in parentheses. *Significance of difference be-
tween value of each parameter in saline solution–treated and
glycine-treated segments, evaluated with the Student t test.
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tissue in control distal segments and was significantly lower
in saline solution–treated distal segments (Fig 7). Potassi-
um-evoked contraction was significantly higher (P  .05)
in glycine-treated segments compared with saline solution–
treated segments (Fig 7).
At 5 mol/L of carbachol, maximal contractile tension
was 44.5 mg per milligram of tissue in control distal seg-
ments and was slightly higher in saline solution–treated
distal segments (Fig 7). Carbachol-evoked contraction was
significantly higher (P  .05) in glycine-treated segments
than in saline solution–treated segments (Fig 7).
DISCUSSION
We evaluated the cytoprotective effect of glycine in
mesenteric ischemia and reperfusion injury in a rat model,
with both histologic and physiologic criteria. For histologic
evaluation, we used a well-established histologic grading
system8 as well as morphometric parameters described by
Gangadharan et al3 for objective assessment of bowel pro-
tection offered by glycine. Because motility is an integral
part of intestinal function, we monitored, for the first time
to our knowledge, the effect of ischemia and reperfusion
injury and of glycine treatment on contractility of isolated
bowel segments, using a new in vitro multimuscle cham-
ber.19 This chamber enabled recording of responses from
proximal, middle, and distal small bowel segments simulta-
neously. We studied changes in proximal, middle, and
distal small bowel segments to control for body changes
due to variation in collateral blood supply to different
regions of the small bowel.
Changes in histologic characteristics of small bowel
segments after ischemia and reperfusion injury or with
treatment with glycine varied with the specific region of the
bowel. Histologic grade significantly increased after isch-
emia and reperfusion injury, and decreased after treatment
with glycine in the middle and distal segments, but not the
proximal segment. Mucosal thickness significantly de-
creased after ischemia and reperfusion injury, and increased
with treatment with glycine in the middle and distal seg-
ments, but not the proximal segment. Villar circumference
ratio significantly decreased after ischemia and reperfusion
injury, and increased with treatment with glycine in the
middle segment, but not the proximal and distal segments.
Muscle thickness and epithelial coverage did not exhibit
significant changes in any bowel segments.
Changes in contractile responses of the small bowel
segments after ischemia and reperfusion injury or treatment
with glycine also varied with specific regions of the bowel.
Electrically-evoked contractile response slightly decreased
after ischemia and reperfusion injury, and significantly in-
creased with treatment with glycine in the middle and distal
segments, but not the proximal segment. Potassium-
evoked contractile response showed a similar trend. How-
ever, carbachol-evoked contraction showed slight decrease
after ischemia and reperfusion injury, and significant in-
crease with treatment with glycine in all three segments of
the bowel. Lack of significant changes in most of the
histologic and contractile parameters of the proximal seg-
ment after ischemia and reperfusion is attributable to insuf-
ficient ischemic injury, because of collateral blood supply to
the proximal segment. The insufficient ischemic injury can
account for lack of significant improvement in histologic
and contractile parameters of the proximal segment after
treatment with glycine.
No morphometric parameters were reliable markers of
ischemia and reperfusion injury or of improvement with gly-
cine treatment. We found no significant change in percentage
of epithelial coverage in proximal, middle, and distal segments
after ischemia and reperfusion injury or with treatment with
glycine. This may be due to the proportionate change in
villous height under these conditions. A similar lack of change
in epithelial cells is evident in the findings of Puglisi et al,22
who measured the number of villous cells per 100- length
after ischemia and reperfusion injury. Significant changes were
noted in transmural thickness, mucosal thickness, and villous
circumference ratio. Inasmuch as muscularis thickness is unal-
tered in this ischemia and reperfusion injury model, transmu-
ral thickness merely reflects changes in mucosal thickness.
Compatible with earlier reports,3 mucosal thickness and villar
circumference ratio were the two most useful morphometric
parameters for evaluating ischemia and reperfusion injury, and
treatment.
Although thickness of the muscularis did not change
significantly, contractility of the bowel segments showed
significant improvement in the glycine-treated animals
compared with saline solution–treated control rats. This is
because changes in contractility can be brought about by
alterations in biochemical and physiologic properties in
absence of any structural change. Our results show that
glycine treatment produces significant improvement in ten-
sion responses evoked with electrical stimulation and with
carbachol in both the middle and distal segments, and
improvement in potassium-induced contractions only in
the distal segments, compared with the saline solution–
treated group. Mechanisms involved in tension generation
differ in the three modes of activation. Contractility of
smooth muscle fibers in the small bowel is mostly caused by
acetylcholine released from the cholinergic nerve terminals,
and may be modulated by adrenergic and polypeptide
neurotransmitters released from other synaptic junctions
located in the small bowel.23 Thus the contractile response
evoked by electrical stimulation of the bowel segment is
caused by cumulative activation by all neurotransmitters
released from the various synaptic junctions. Contraction
evoked with carbachol is caused by specific activation of the
muscarinic receptors.21 Contraction evoked with high
doses of potassium is caused by direct depolarization of the
smooth muscle membrane by potassium, leading to eleva-
tion in myoplasmic Ca2 concentration.20 Significantly
greater improvement with glycine in contraction of the
bowel segments evoked with electrical stimulation and
carbachol, compared with potassium, indicates that glycine
may provide greater protection for neurogenic than for
myogenic contractility during ischemia and reperfusion
injury. This hypothesis is consistent with an earlier report
that showed that hypoxia induced with high temperature
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causes greater reduction in muscle contractions evoked with
nerve stimulation than with direct muscle stimulation.24 In
view of these results, it may be suggested that glycine affords
protection by modulating the action of neurotransmitters
rather than directly affecting intestinal smooth muscle fibers
during ischemia and reperfusion injury.
The mechanism of cytoprotection offered by glycine is
not fully understood. It has been proposed that, in hypoxic
conditions, cellular levels of adenosine triphosphate are
maintained by stimulating anaerobic glucose metabolism
with amino acids and their intermediary metabolites.25-27
Mangino et al11 suggested that higher adenosine triphos-
phate levels observed after glycine administration actually
reflect preservation of more viable cells and thus explain the
cytoprotection offered by glycine. Weinberg et al27 pro-
posed that glycine may have a role in detoxification of
acyl–coenzyme A thioesters produced during ischemia,
which contribute to disruption of cell membranes and struc-
tural components of cells. The enzyme glycine-N-acetyltrans-
ferase catalyzes formation of acyl-glycine from acyl–coenzyme
A, which helps scavenge intracellular detergents. Baines et al28
proposed that the neutral amino acids exert cytoprotective
effect with their ability to stabilize the tertiary protein struc-
ture of cell membranes. Weinberg et al29 hypothesized that a
unique steric physicochemical property of glycine may be the
cause of this membrane stabilizing effect.
It has long been known that glycine is an inhibitory
neurotransmitter between the spinal interneurons and mo-
tor neurons.14 Ischemic spinal cord injury is partly attrib-
uted to excessive release of excitatory neurotransmitters.15
Our contractile studies showed that glycine significantly
improves the neurogenic contractile responses of ischemic
bowel segments. In view of these considerations, it may be
suggested that glycine affords protection by acting as an
inhibitory neurotransmitter and thus reducing the injurious
effects of excitatory substances that may be released to
excess during ischemia and reperfusion of the small bowel.
CONCLUSIONS
Glycine improves mucosal viability of the small bowel
after mesenteric ischemia and reperfusion injury in the rat
model. In addition to histologic grading, mucosal thickness
and villous circumference ratio are reliable objective param-
eters for evaluation of intestinal ischemia injury. Glycine im-
proves the contractile responses of the bowel segments, also
probably by altering the physiologic mechanisms underlying
force generation. Further studies are required to elucidate the
mechanism of cytoprotective action of glycine.
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